SEC Form 4 · accession 0001179110-17-009442
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven C Gilman
Director
Period of report
Jun 20, 2017
Accepted (ET)
Jun 22, 2017 · 3:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $17.20 | Jun 20, 2017 | A | 11,207 | A | — | Jun 20, 2027 | Common Stock | 11,207 | 11,207 | D |
| Restricted Stock UnitsF2,F3 | — | Jun 20, 2017 | A | 5,734 | A | — | — | Common Stock | 5,734 | 5,734 | D |
Explanation of responses
- F1Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan. The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Gilman's continued service to the Company.
- F2Each restricted stock unit represents a contingent right to receive one share of MNTA common stock.
- F3Represents 5,734 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Gilman's continued service to the Company.